The level of insulin-like growth factor receptor β subunit (IGFRβ) in plasma sEVs [40] and CD82 in serum sEVs [157] was found to gradually increase with BC grade, showing the potential of these protein biomarkers for monitoring BC progression or prediction of disease prognosis. Here, CD82 is linked to breast cancer.